RxDoctor Payments Data

Ricardo Gonzalez, MD

Surgical Oncology · Tampa, FLNPI 1275632929

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $5,700 of the $6,685 with a category attached, or 85.3%. Baxter Healthcare accounts for 88.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2020 at $5,801 and has fallen 98.4% since, to $92 in 2024.

$6,685in general payments, 2019–2025

Across 22 payments — averaging $303.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Baxter Healthcare$6K
  • Boston Scientific$492
  • Medtronic$170
  • AbbVie$89
  • Eisai Inc.$21

What the payments were for

  • Consulting fees$5,70085%
  • Travel & lodging$621%
  • Food & beverage$92314%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Baxter Healthcare5$5,912
Boston Scientific9$492
Medtronic1$170
AbbVie6$89
Eisai Inc.1$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,685 in reported general payments places this provider in the 70th percentile of 133 surgical oncology providers in Florida.

See all surgical oncology providers in Florida

Medicare billing

Part B allowed, 2024
$161,099
Medicare patients
184
Services billed
478

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgical oncology in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →